Cargando…
Validation of AAC-11-Derived Peptide Anti-Tumor Activity in a Single Graft Sézary Patient-Derived Xenograft Mouse Model
Sézary syndrome (SS) is an aggressive cutaneous T cell lymphoma with poor prognosis mainly characterized by the expansion of a tumor CD4(+) T cell clone in both skin and blood. So far, the development of new therapeutic strategies has been hindered by a lack of reproducible in vivo models closely re...
Autores principales: | Habault, Justine, Thonnart, Nicolas, Ram-Wolff, Caroline, Bagot, Martine, Bensussan, Armand, Poyet, Jean-Luc, Marie-Cardine, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564267/ https://www.ncbi.nlm.nih.gov/pubmed/36230895 http://dx.doi.org/10.3390/cells11192933 |
Ejemplares similares
-
Prophylactic and therapeutic antileukemic effects induced by the AAC-11-derived Peptide RT53
por: Habault, Justine, et al.
Publicado: (2020) -
Efficient Therapeutic Delivery by a Novel Cell-Penetrating Peptide Derived from Acinus
por: Habault, Justine, et al.
Publicado: (2020) -
Large‐cell transformation is an independent poor prognostic factor in Sézary syndrome: analysis of 117 cases
por: Bontoux, Christophe, et al.
Publicado: (2022) -
Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies
por: Habault, Justine, et al.
Publicado: (2019) -
The anticancer peptide RT53 induces immunogenic cell death
por: Pasquereau-Kotula, Ewa, et al.
Publicado: (2018)